Chapter 3 : Microbial Pathogenic Factors: Small-Colony Variants

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in

Microbial Pathogenic Factors: Small-Colony Variants, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818067/9781555811778_Chap03-1.gif /docserver/preview/fulltext/10.1128/9781555818067/9781555811778_Chap03-2.gif


A variant subpopulation of has been characterized that is defective in electron transport. These organisms grow slowly and are typical of the small-colony variants (SCVs), which were found to be defective in respiratory activity. Recent work has shown that most of the clinical isolates have inactive electron transport because of biosynthetic defects in the pathways leading to the synthesis of electron transport chain components. The changes in membrane potential and ATP also suggest that electron transport is decreased in both SCVs and adherent bacteria. SCVs from a variety of genera and species have most frequently been isolated from patients and animals treated with antibiotics, especially aminoglycosides, but also sulfonamides and β-lactam antibiotics. The host environment may favor the selection of staphylococcal SVCs. The basis for the persistent and antibiotic resistant infections may be related to the ability of SCVs to reside within cultured cells. Pigment formation and aminoglycoside transport require ATP and an intact electron transport system. The yellow carotenoid pigments that give SCV colonies their characteristic color require ATP for their biosynthesis. Menadione and hemin are the two most frequent substances that reverse the SCV phenotype. In addition, thiamine is a co-factor used in menadione biosynthesis and CO may be involved in the synthesis of the porphyrin ring found in hemin.

Citation: Proctor R. 2000. Microbial Pathogenic Factors: Small-Colony Variants, p 41-54. In Waldvogel F, Bisno A (ed), Infections Associated with Indwelling Medical Devices, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818067.ch3
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


Image of Figure 1
Figure 1

Clinical SCVs are often auxotrophic for menadione or hemin. These variants have defects in either menadione or hemin biosynthesis, making their electron transport chain inactive because they cannot synthesize menaquinone or the hemin portion of cytochromes. The organisms may also be auxotrophic for thiamine since this is a co-factor needed for menadione biosynthesis. Similarly, defects in cytochrome protein biosynthesis also give the SCV phenotype ( ). The F0F1 ATPase is a group of five proteins spanning the membrane that synthesizes ATP and creates an electrochemical gradient by using electrons transferred from the cytochromes. When large amounts of ATP are not available, cell wall biosynthesis slows, which results in small colonies. Decreases in the large electrochemical gradient cause reduced pigment biosynthesis and binding/transport of cationic compounds into staphylococci, leading to nonpigmented colonies that are more resistant to some antibiotics. Finally, interruption of electron transport is postulated to stimulate the production of negative regulators since SCVs show greatly decreased production of toxins. Therefore, interruption of electron transport can account for all of the phenotypic changes seen in SCVs.

Citation: Proctor R. 2000. Microbial Pathogenic Factors: Small-Colony Variants, p 41-54. In Waldvogel F, Bisno A (ed), Infections Associated with Indwelling Medical Devices, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818067.ch3
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 2
Figure 2

Transmission electron micrograph of a menadione auxotrophic SCV, JB-1 (6). The organism was grown on tryptic soy broth, a low menadione-containing medium, and then incubated for 3.5 h at 35°C with bovine endothelial cells (6). Extracellular JB-1 cells were destroyed by addition of lysostaphin. After 18 h of further incubation, the endothelial monolayer was again treated with lysostaphin and washed and then prepared for transmission electron microscopy. Organisms with the endothelial cell are highlighted with arrows. Of note, the cellular architecture of the endothelial cell is very well preserved, as evidenced by intact mitochondria, philopodia, and other cytoplasmic structures, thus suggesting that the SCVs are causing minimal disruption to this mammalian cell.

Citation: Proctor R. 2000. Microbial Pathogenic Factors: Small-Colony Variants, p 41-54. In Waldvogel F, Bisno A (ed), Infections Associated with Indwelling Medical Devices, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818067.ch3
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 3
Figure 3

(A) A hemin auxotrophic SCV, S. aureus PvL-3, is shown on the left side of this tryptic soy agar plate. This disc contains 1 µg of hemin/ml, which is sufficient to relieve the auxotrophy and allow the SCV to grow normally. The parent strain, 6850, is shown on the right half of the plate. The organisms were grown on tryptic soy agar and incubated for 36 h at 35°C. PvL-3 was selected by exposing the parent strain to 1 µg of gentamicin/ml for 3 days in tryptic soy broth (6). (B) A menadione auxotrophic SCV, JB-1, growing rapidly around a piece of filter paper that was supplemented with 1 µg of menadione/ml. In each case, the supplementation allows for rapid growth of the organism (large colonies that are pigmented).

Citation: Proctor R. 2000. Microbial Pathogenic Factors: Small-Colony Variants, p 41-54. In Waldvogel F, Bisno A (ed), Infections Associated with Indwelling Medical Devices, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818067.ch3
Permissions and Reprints Request Permissions
Download as Powerpoint


1. Acar, J. F.,, F. N. Goldstein,, and P. Lagrange. 1978. Human infections caused by thiamine- or menadione-requiring Staphylococcus aureus. J. Clin. Microbiol. 8: 142 147.
2. Arizono, T.,, M. Oga,, and Y. Sugioka. 1992. Increased resistance of bacteria after adherence to polymethyl methacrylate. An in vitro study. Acta Orthop. Scand. 63: 661 664.
3. Baddour, L. M.,, G. D. Christensen,, J. H. Lowrance,, and W. A. Simpson. 1989. Pathogenesis of experimental endocarditis. Rev. Infect. Dis. 11: 452 463.
4. Baddour, L. M.,, W. A. Simpson,, J. J. Weems, Jr.,, M. M. Hill,, and G. D. Christensen. 1988. Phenotypic selection of small-colony variant forms of Staphylococcus epidermidis in the rat model of endocarditis. J. Infect. Dis. 157: 757 763.
5. Baddour Balwit, J. M. 1992. Intracellular persistence of a Staphylococcus aureus small-colony variant. M.S. thesis. University of Wisconsin, Madison.
6. Balwit, J. M.,, P. van Langevelde,, J. M. Vann,, and R. A. Proctor. 1994. Gentamicin-resistant menadione and hemin auxotrophic Staphylococcus aureus persist within cultured endothelial cells. J. Infect. Dis. 170: 1033 1037.
7. Barbour, R. G. H. 1950. Small colony variants (“G” forms) produced by Staphylococcus pyogenes during the development of resistance to streptomycin. Aust. J. Exp. Biol. Med. Sci. 28: 411 420.
8. Bayer, A. S.,, D. C. Norman,, and K. S. Kim. 1987. Characterization of Pseudomonas aeruginosa isolated during unsuccessful therapy of experimental endocarditis. Antimicrob. Agents Chemother. 31: 70 75.
9. Bentley, R.,, and R. Meganathan. 1982. Biosynthesis of vitamin K (menaquinone) in bacteria. Microb. Rev. 46: 241 280.
10. Bisno, A. L., 1989. Infections of central nervous system shunts, p. 93 109. In A. L. Bisno, and F. A. Waldvogel (ed.), Infections Associated with Indwelling Medical Devices, 1st ed. American Society for Microbiology, Washington, D.C.
11. Borderon, E.,, and T. Horodniceanu. 1976. Mutants deficients a colonies naines de Staphylococcus: etude de trois souches isolees chez des malades porteurs d'osteosyntheses. Ann. Micro. Inst. Pasteur. 127A: 503 514.
12. Borgna-Pignatti, C.,, P. Marradi,, L. Pinelli,, N. Monetti,, and C. Patrini. 1989. Thiamine-responsive anemia in DIDMOAD syndrome. J. Pediatr. 114: 405 410.
13. Brown, M. R.,, P. J. Collier,, and P. Gilbert. 1990. Influence of growth rate on susceptibility to antimicrobial agents: modification of the cell envelope and batch and continuous culture studies. Antimicrob. Agents Chemother. 34: 1623 1628.
14. Browning, C. H.,, and H. S. Adamson. 1950. Stable dwarf-colony forms produced by Staphylococcus pyogenes. J. Pathol. Bacterial. 62: 499 500.
15. Bryan, L. E.,, and H. M. van den Elzen. 1977. Effects of membrane-energy mutations and cations on streptomycin and gentamicin accumulation by bacteria: a model for entry of streptomycin and gentamicin in susceptible and resistant bacteria. Antimicrob. Agents Chemother. 12: 163 177.
16. Bryan, L. E.,, and S. Kwan. 1981. Aminoglycoside-resistant mutants of Pseudomonas aeruginosa deficient in cytochrome d, nitrate reductase, and aerobic transport. Antimicrob. Agents Chemother. 19: 958 964.
17. Bulger, R. J. 1967. A methicillin-resistant strain of Staphylococcus aureus. Clinical and laboratory experience. Ann. Intern. Med. 67: 81 89.
18. Chambers, H. F.,, and M. M. Miller. 1987. Emergence of resistance to cephalothin and gentamicin during combination therapy for methicillin-resistant Staphylococcus aureus endocarditis in rabbits. J. Infect Dis. 155: 581 585.
19. Chin, Y. M.,, and S. A. Harmon. 1971. Genetic studies of kanamycin resistance in Staphylococcus aureus. Jpn. J. Microbiol. 15: 417 423.
20. Chinn, B. D. 1936. Characteristics of small colony variants with special reference to Shigella paradysenteriae sonne. J. Infect. Dis. 59: 137 151.
21. Chinn, B. D. 1936. Characteristics of small colony variants of Shigella paradysenteriae sonne. and Staphylococcus aureus. Proc. Soc. Exp. Biol. Med. 34: 237 238.
22. Chuard, C.,, M. Herrmann,, P. Vaudaux,, F. A. Waldvogel,, and D. P. Lew. 1991. Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations. Antimicrob. Agents Chemother. 35: 2611 2616.
23. Chuard, C.,, P. E. Vaudaux,, R. A. Proctor,, and D. P. Lew. 1997. Decreased susceptibility to antibiotic killing of a stable small colony variant of Staphylococcus aureus in fluid phase and on fibronectin-coated surfaces. J. Antimicrob. Chemother. 39: 603 608.
24. Chuard, C.,, P. Vaudaux,, F. A. Waldvogel,, and D. P. Lew. 1993. Susceptibility of Staphylococcus aureus growing on fibronectin-coated surfaces to bactericidal antibiotics. Antimicrob. Agents Chemother. 37: 625 632.
24a. Clements, M. O.,, S. P. Watson,, R. K. Poole,, and S. J. Foster. 1999. CtaA of Staphylococcus aureus is required for starvation survival, recovery, and cytochrome biosynthesis. J. Bacteriol. 181: 501 507.
25. Colien, E. E. 1935. A study of microbic variation in a yellow pigment-producing coccus. J. Bacteriol. 30: 301 321.
26. Colwell, C. A. 1946. Small colony variants of Escherichia coli. J. Bacteriol. 52: 417 422.
27. Devriese, L. A. 1973. Hemin-dependent mutants isolated from methicillin-resistant Staphylococcus aureus strains. Antonie Van Leeuwenhoek. J. Microbiol. Serol. 39: 33 40.
28. Dietz, A. S.,, L. I. Albright,, T. Tuominen. 1976. Heterotrophic activities of bacterioneuston and bacteri-oplankton. Can. J. Microbiol. 22: 1699 1709.
29. Dworkin, R.,, G. Modin,, S. Kunz,, O. Rich,, O. Zak,, and M. Sande. 1990. Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis. Antimicrob. Agents Chemother. 34: 1014 1016.
30. Evans, D. J.,, D. G. Allison,, M. R. W. Brown,, and P. Gilbert. 1991. Susceptibility of Pseudomonas aeruginosa and Escherichia coli biofilms toward ciprofloxacin: effect of specific growth rate. J. Antimicrob. Chemother. 27: 177 184.
31. Fujiswara, S.,, Y. Miyake,, T. Usui,, and H. Suginaka. 1998. Effect of adherence on antimicrobial susceptibility of Pseudomonas aeruginosa, Serratia marcescens, and Proteus mirabilis. Hiroshima J. Med. Sci. 47: 1 5.
32. Goudie, J. G.,, and R. B. Goudie. 1955. Recurrent infection by a stable dwarf-colony variant of Staphylococcus aureus. J. Clin. Pathol. 8: 284 287.
33. Hadley, P.,, and H. Carapetian. 1933. A study of the infective qualities possessed by G phase pleomorphism and filterability. J. Bacteriol. 25: 94 96.
34. Hale, J. H. 1947. Studies on staphylococcal mutation: characterization of the "G" (gonidial) variant and factors concerned in its production. Br. J. Exp. Pathol. 28: 202 210.
35. Hale, J. H. 1951. Studies on Staphylococcus mutation: a naturally occurring "G" gonidial variant and its carbon dioxide requirements. Br. J. Exp. Pathol. 32: 307 313.
36. Haung, C. T.,, F. P. Yu,, G. A. McFeters,, and P. S. Stewart. 1995. Nonuniform spatial patterns of respiratory activity within biofilms during disinfection. Appl. Environ. Microbiol. 61: 2252 2256.
37. Henry, N. K.,, M. S. Rouse,, A. L. Whitesell,, M. E. McConnell,, and W. R. Wilson. 1987. Treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin. Am. J. Med. 82( Suppl. 4A): 73 75.
38. Hoffstadt, R. E.,, and G. P. Youmans. 1932. Staphylococcus aureus: dissociation and its relation to infection and to immunity. J. Infect. Dis. 51: 216 242.
39. Huddleson, I. F.,, and B. Baltzer. 1952. The characteristics and dissociation pattern of type G (micro-colony type) of Brucella arbortus, p. 64 83. In Studies in Brucellosis III. A series of five papers. Dep. Bacteriol. Public Health, Agric. Exp. Station, Michigan State College, East Lansing, Mich.
40. Jensen, J. 1957. Biosynthesis of hematin compounds in a hemin requiring strain of Micrococcus pyogenes var . aureus. J. Bacteriol. 73: 324 333.
41. Joyce, G. H.,, and D. C. White. 1971. Effects of benso(a)pyrene and piperonyl butoxide on formation of respiratory system, phospholipids, and carotenoids of Staphylococcus aureus. J. Bacteriol. 106: 403 411.
42. Kahl, B.,, R. A. Proctor,, and G. Peters. 1996. Staphylococcal small colony variants present a challenge to clinicians and clinical microbiologists. Antimicrob. Infect. Dis. News 15: 59 63.
43. Kahl, B.,, R. A. Proctor,, A. Schulze-Everding,, M. Herrmann,, H. G. Koch,, I. Harms,, and G. Peters. 1998. Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J. Infect. Dis. 177: 1023 1029.
44. Kaplan, M. L.,, and W. E. Dye. 1976. Growth requirements of some small-colony-forming variants of Staphylococcus aureus. J. Clin. Microbiol. 4: 343 348.
45. Kolle, W.,, and H. Hetsch. 1911. Die experimented Bacteriologie und die Infectionskrankheiten mit besonderer Bertticksichtigung der Immunitdtslehre, vol. 1. 3rd ed. Urban und Schwarzenberg, Berlin, Germany.
46. Koneman, E. W.,, S. D. Allen,, V. R. Dowell, Jr.,, and H. M. Sommers. 1979. Color Atlas and Textbook of Diagnostic Microbiology, 2nd ed., p. 264 265. J. B. Lippincott, Philadelphia, Pa.
47. Koo, S.-P.,, A. S. Bayer,, H.-G. Sahl,, R. A. Proctor,, and M. R. Yeaman. 1996. Staphylocidal action of thrombin-induced platelet microbicidal protein (tPMP) is not solely dependent on transmembrane potential (A*). Infect. Immun. 64: 1070 1074.
48. Kopeleff, N. 1934. Dissociation and filtration of Lactobacillus acidophilus. J. Infect. Dis. 55: 368 389.
49. Kullik, I.,, P. Giachino,, and T. Fuchs. 1998. Deletion of the alternative sigma factor, sigmaB, in Staphylococcus aureus reveals its function as a global regulator of virulence genes. J. Bacteriol. 180: 4814 4820.
50. Lacy, R. W. 1969. Dwarf-colony variants of Staphylococcus aureus resistant to aminoglycoside antibiotics and to a fatty acid. J. Med. Microbiol. 2: 187 197.
51. Lacy, R. W.,, and A. A. B. Mitchell. 1969. Gentamicin-resistant Staphylococcus aureus. Lancet ii: 1425 1426.
52. Lewis, L. A.,, K. Li,, M. Bharosay,, M. Cannella,, V. Jorgenson,, R. Thomas,, D. Pena,, M. Velez,, B. Pereira,, and A. Sassine. 1990. Characterization of gentamicin-resistant respiratory-deficient (Res -) variant strains of Staphylococcus aureus. Microbiol. Immunol. 34: 587 605.
53. Li, K.,, J. J. Fanner III,, and A. Coppola. 1974. A novel type of resistant bacteria induced by gentamicin. Trans. N.Y. Acad. Sci. 36: 396 415.
54. McCabe, K.,, M. D. Mann,, and M. D. Bowie. 1998. D-Lactate production and [ 14C] succinic acid uptake by adherent and nonadherent Escherichia coli. Infect. Immun. 66: 907 911.
55. Miller, M. H.,, S. C. Edberg,, L. J. Mandel,, F. C. Behar,, and N. H. Steigbigel. 1980. Gentamicin uptake in wild type and aminoglycoside-resistant small colony mutants of Staphylococcus aureus. Antimicrob. Agents Chemother. 18: 722 729.
56. Miller, M. H.,, M. A. Wexler,, and N. H. Steigbigel. 1978. Single and combination antibiotic therapy of Staphylococcus aureus experimental endocarditis: emergence of gentamicin mutants. Antimicrob. Agents Chemother. 14: 336 343.
57. Morton, H. E.,, and J. Shoemaker. 1945. The identification of Neisseria gonorrhoeae by means of bacterial variation and the detection of small colony forms in clinical material. J. Bacteriol. 50: 585 590.
58. Musher, D. M.,, R. E. Baughn,, G. B. Templeton,, and J. N. Minuth. 1977. Emergence of variant forms of Staphylococcus aureus after exposure to gentamicin and infectivity of the variants in experimental animals. J. Infect. Dis. 136: 360 369.
59. Nydahl, B. C, and W. L. Hall. 1965. The treatment of staphylococcal infection with nafcillin with a discussion of staphylococcal nephritis. Ann. Intern. Med. 63: 27 43.
60. Padmanaban, G.,, V. Venkateswar,, and P. N. Rangarajan. 1989. Haem as a multifunctional regulator. Trends Biochem. Sci. 14: 492 496.
61. Pelletier, L. L., Jr.,, M. Richardson,, and M. Feist. 1979. Virulent gentamicin-induced small colony variants of Staphylococcus aureus. J. Lab. Clin. Med. 94: 324 334.
62. Proctor, R. A. 1998. Bacterial energetics and antimicrobial resistance. Drug Resist. Updates 1: 227 235.
63. Proctor, R. A., 2000. Respiration and small-colony variants of Staphylococcus aureus, p. 345 350. In V. A. Fischetti,, R. P. Novick,, J. J. Ferretti,, D. A. Portnoy,, and J. I. Rood (ed.), Gram-Positive Pathogens. ASM Press, Washington, D.C.
64. Proctor, R. A. J. M. Balwit,, and O. Vesga. 1994. Variant subpopulations of Staphylococcus aureus as cause of persistent and recurrent infections. Infect. Agents Dis. 3: 302 312.
65. Proctor, R. A.,, and G. Peters. 1998. Small colony variants in staphylococcal infections: diagnostic and therapeutic implications. Clin. Infect. Dis. 27: 419 423.
66. Proctor, R. A.,, B. Kahl,, C. von Eiff,, P. E. Vaudaux,, D. P. Lew,, and G. Peters. 1998. Staphylococcal small colony variants have novel mechanisms for antibiotic resistance. Clin. Infect. Dis. 27( Suppl. 1): S68 S74.
67. Proctor, R. A.,, P. van Langevelde,, M. Kristjansson,, J. N. Maslow,, and R. D. Arbeit. 1995. Persistent and relapsing infections associated with small colony variants of Staphylococcus aureus. Clin. Infect. Dis. 20: 95 102.
68. Proctor,, R. A. O. Vesga,, M. F., Otten,, S.-P. Koo,, M. R. Yeaman,, H.-G. Sahl,, and A. S. Bayer. 1996. Staphylococcus aureus small colony variants cause persistent and resistant infections. Chemotherapy 42( Suppl. 2): 47 52.
69. Quie, P. G. 1969. Microcolonies (G variants) of Staphylococcus aureus. Yale J. Biol. Med. 41: 394 403.
70. Sasarman, A.,, K. E. Sanderson,, M. Surdeanu,, and S. Sonea. 1970. Hemin-deficient mutants of Salmonella typhimurium. J. Bacteriol. 102: 531 536.
71. Sasarman, A.,, M. Surdeanu,, V. Portelance,, R. Dobardzic,, and S. Sorrea. 1971. Classification of vitamin K-deficient mutants of Staphylococcus aureus. J. Gen. Microbiol. 65: 125 130.
72. Sasarman, A.,, M. Surdeanu,, J. Sabados,, V. Greceanu,, and T. Horodniceanu. 1968. Menaphthone requiring mutants of Staphylococcus aureus. Rev. Can. Biol. 23: 333 340.
73. Sasarman, A.,, and T. Horodniceanu. 1967. Locus determining normal colony formation on the chromosome of Escherichia coli K12. J. Bacteriol. 94: 1268 1269.
74. Schierholz, J. M.,, J. Beuth,, and B. Pulverer. 1999. Adherent bacteria and activity of antibiotics. J. Antimicrob. Chemother. 43: 158 160.
75. Schnitzer, R. J.,, L. J. Canagni,, and M. Back. 1943. Resistance of small colony variants (G forms) of a Staphylococcus toward the bacteriostatic activity of penicillin. Proc. Soc. Exp. Biol. Med. 53: 75 78.
76. Schwank, S.,, A. Rajacic,, W. Zimmerli,, and J. Blaser. 1998. Impact of bacterial biofilm formation on in vitro and in vivo activities of antibiotics. Antimicrob. Agents Chemother. 42: 895 898.
77. Seifert, H.,, C. von Eiff,, and G. Fätkenheuer. 1999. Fatal case due to methicillin-resistant Staphylococcus aureus small colony variants in an AIDS patient. Emerg. Infect. Dis. 5: 450 452.
78. Shearer, M. J.,, P. T. McCarthy,, O. E. Crampton,, and M. B. Mattock,. 1987. The assessment of human vitamin K status from tissue measurements, p. 437 452. In J. W. Suttie (ed.), Current Advances in Vitamin K Research. Elsevier, New York, N.Y.
79. Sherris, J. C. 1952. Two small colony variants of Staphylococcus aureus isolated in pure culture from closed infected lesions and their carbon dioxide requirements. J. Clin. Pathol. 5: 354 355.
80. Short, S. A.,, D. C. White,, and H. R. Kaback. 1972. Active transport in isolated bacterial membrane vesicles. V. The transport of amino acids by membrane vesicles prepared from Staphylococcus aureus. J. Biol. Chem. 247: 298 304.
81. Slifkin, M.,, L. P. Merkow,, S. A. Kreuzberger,, C. Engwall,, and M. Pardo. 1971. Characterization of CO 2 dependent microcolony variants of Staphylococcus aureus. Am. J. Clin. Pathol. 56: 584 592.
82. Sompolinsky, D.,, M. Cohen,, and G. Ziv. 1974. Epidemiological studies on thiamine-less dwarf-colony variants of Staphylococcus aureus as etiologic agents of bovine mastitis. Infect. Immun. 9: 217 228.
83. Sompolinsky, D.,, Z. E. Geller,, and S. Segal. 1967. Metabolic disorders in thiamine-less dwarf strains of Staphylococcus aureus. J. Gen. Microbiol. 48: 205 213.
84. Spagna, V. A.,, R. J. Fass,, R. B. Prior,, and T. G. Slama. 1978. Report of a case of bacterial sepsis caused by a naturally occurring variant form of Staphylococcus aureus. J. Infect. Dis. 138: 277 278.
85. Swingle, E. L. 1934. Studies on small colony variants of Staphylococcus aureus. Proc. Soc. Exp. Biol. Med. 31: 891 893.
86. Swingle, E. L. 1935. Studies on a small colony variant of Staphylococcus aureus. J. Bacteriol. 29: 467 490.
87. Thomas, M. E. M.,, and J. H. Cowlard. 1955. Studies on a C0 2-dependent Staphylococcus. J. Clin. Pathol. 8: 288 291.
88. Tien, W.,, and D. C. White. 1968. Linear sequential arrangement of genes for the biosynthetic pathway of protoheme in Staphylococcus aureus. Proc. Natl. Acad. Sci. USA 61: 1392 1398.
89. Vann, J. M.,, and R. A. Proctor. 1988. Cytotoxic effects of ingested Staphylococcus aureus on bovine endothelial cells: role of S. aureus a-hemolysin. Microb. Pathog. 4: 443 453.
90. Vergeres, P.,, and J. Blaser. 1992. Amikacin, ceftazidime, and flucloxacillin against suspended and adherent Pseudomonas aeruginosa and Staphylococcus epidermidis in an in vitro model of infection. J. Infect. Dis. 165: 281 289.
91. Vesga, O.,, M. C. Groeschel,, M. F. Otten,, D. W. Brar,, J. M. Vann,, and R. A. Proctor. 1996. Staphylococcus aureus small colony variants are induced by the endothelial cell intracellular milieu. J. Infect. Dis. 173: 739 742.
92. von Eiff, C.,, D. Bettin,, R. A. Proctor,, B. Rolauffs,, N. Lindner,, W. Winkelmann,, and G. Peters. 1997. Recovery of small colony variants of Staphylococcus aureus following gentamicin bead placement for osteomyelitis. Clin. Infect. Dis. 25: 1250 1251.
93. von Eiff, C.,, C. Heilmann,, R. A. Proctor,, C. Woltz,, G. Peters,, and F. Gotz. 1997. A site directed Staphylococcus aureus hemB mutant is a small colony variant which persists intracellularly. J. Bacteriol. 179: 4706 4712.
94. von Eiff, C.,, N. Lindner,, R. A. Proctor,, W. Winkelmann,, and G. Peters. 1998. Isolation of small colony variants of Staphylococcus aureus following gentamicin bead placement for osteomyelitis as a possible cause for recurrence. Z. Orthop. 136: 268 271.
95. von Eiff, C.,, P. Vaudaux,, B. Kahl,, D. P. Lew,, S. Emler,, A. Schmidt,, G. Peters, and R. A. Proctor. 1999. Bloodstream infections caused by small-colony variants of coagulase negative staphylococci following pacemaker placements. Clin. Infect. Dis. 29: 932 934.
96. Weinberg, E. D. 1950. Vitamin requirements of dwarf colony variants of bacteria. J. Infect. Dis. 87: 299 306.
97. Widmer, A. F.,, A. Wiestner,, R. Frei,, and W. Zimmerli. 1991. Killing of nongrowing and adherent Escherichia coli determines drug efficacy in device-related infections. Antimicrob. Agents Chemother. 35: 741 746.
98. Wilson, S. G.,, and C. C. Sanders. 1976. Selection and characterization of strains of Staphylococcus aureus displaying unusual resistance to aminoglycosides. Antimicrob. Agents Chemother. 10: 519 525.
99. Wise, R. 1. 1956. Small colonies (G variants) of staphylococci: isolation from cultures and infections. Ann. N.Y. Acad. Sci. 65: 169 174.
100. Wise, R. I.,, and W. W. Spink. 1954. The influence of antibiotics on the origin of small colony (G variants) of Micrococcus pyogenes var. aureus. J. Clin. Invest. 33: 1611 1622.
101. Yegian, D.,, G. Gallo,, and M. W. Toll. 1959. Kanamycin resistant staphylococcus mutants requiring hemin for growth. J. Bacteriol. 78: 10 12.
102. Youmans, G. P. 1937. Production of small colony variants of Staphylococcus aureus. Proc. Soc. Exp. Biol. Med. 36: 94 98.
103. Youmans, G. P.,, and E. Delves. 1942. The effect of inorganic salts on the production of small colony variants by Staphylococcus aureus. J. Bacteriol. 44: 127 136.
104. Youmans, G. P.,, E. H. Williston,, and M. Simon. 1945. Production of small colony variants of Staphylococcus aureus by the action of penicillin. Proc. Soc. Exp. Biol. Med. 58: 56 57.
105. Yu, F. P.,, and G. A. McFeters. 1994. Physiological responses of bacteria in biofilms to disinfection. Appl. Environ. Microbiol. 60: 2462 2466.


Generic image for table
Table 1

Comparison of SCVs and adherent bacteria

Citation: Proctor R. 2000. Microbial Pathogenic Factors: Small-Colony Variants, p 41-54. In Waldvogel F, Bisno A (ed), Infections Associated with Indwelling Medical Devices, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818067.ch3

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error